Library

Désoxypipradrol

Desoxypipradrol is a benzylpiperidine-based stimulant structurally related to methylphenidate and pipradrol. Developed by Ciba in the 1950s for conditions such as narcolepsy and ADHD, it was ultimately abandoned in favor of methylphenidate. It acts as a norepinephrine-dopamine reuptake inhibitor and is distinguished by its exceptionally long duration of action, a consequence of its high lipophilicity which renders it resistant to metabolic breakdown. It resurfaced as a recreational substance in the late 2000s.

Désoxypipradrol molecular structure
Désoxypipradrol molecular structure diagram from the DrugsPRO substance library.

Also known as: Pippy, 2-dpmp, Ivory wave, Vanillasky, Purple wave, 2‑diphenylmethylpiperidine, 2‑desoxypiperadol

Classification

  • Psychoactive: Stimulant
  • Tag: Benzylpiperidine
  • Tag: Habit-Forming
  • Tag: Pipradrol homologue
  • Tag: Research-Chemical
  • Tag: substituted piperidine
  • Tag: Tentative

Effects

  • Stimulation
  • Increased Heart Rate
  • Increased Perspiration
  • Bruxism
  • Itchiness
  • Muscle Spasms
  • Euphoria
  • Anxiety
  • Irritability
  • Paranoia
  • Sociability Enhancement
  • Wakefulness
  • Increased Libido
  • Appetite Suppression
  • Auditory Hallucination
  • External Hallucination
  • Increased Sexuality
  • Visual And Auditory Hallucinations

Routes of Administration

Insufflated

Dosage

  • Heavy: 5+ mg
  • Light: 2 mg
  • Common: 1.5 – 3.5 mg
  • Strong: 3.5 – 5 mg
  • Threshold: 1-2 mg

Duration

  • Onset: 0.33-1 h
  • Comeup: 2-6 h
  • Peak: 6-30 h
  • Offset: 6-40 h
  • After Effects: 1-72 h

Oral

Dosage

  • Heavy: 8+ mg
  • Light: 0.25 – 2 mg
  • Common: 2 – 6 mg
  • Strong: 6 – 8 mg
  • Threshold: 1-2 mg

Duration

  • Onset: 1-2 h
  • Peak: 9-30 h
  • Offset: 12-36 h
  • After Effects: 24-72 h
  • Total Duration: 16-72 h

Oral & Intranasal

Dosage

  • Heavy: 8 mg
  • Light: 2 – 3 mg
  • Common: 4 – 6 mg
  • Strong: 7 – 8 mg
  • Threshold: 2 mg

Duration

  • Onset: 1-2 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

Desoxypipradrol - Guide des substances DrugsPRO

Desoxypipradrol: Desoxypipradrol is a benzylpiperidine-based stimulant structurally related to methylphenidate and pipradrol. Developed by Ciba in the 1950s for conditions such as narcolepsy and ADHD, it was ultimately abandoned in favor of methylphenidate. It acts as a norepinephrine-dopamine reupt

Related pages